Center-Authored Papers

Filters: Author is Simon, Michael S  [Clear All Filters]
Journal Article
Chlebowski RT, Rohan TE, Manson JE, Aragaki AK, Kaunitz A, Stefanick ML, Simon MS, Johnson KC, Wactawski-Wende J, O'Sullivan MJ et al..  2015.  Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials.. JAMA oncology. 1(3):296-305. Abstract
Pressler M, Rosenberg CA, Derman BA, Greenland P, Khandekar J, Rodabough RJ, McTiernan A, Simon MS.  2013.  Breast cancer in postmenopausal women after non-melanomatous skin cancer: the Women's Health Initiative observational study.. Breast cancer research and treatment. 139(3):821-31. Abstract
Ma H, Wang Y, Sullivan-Halley J, Weiss L, Burkman RT, Simon MS, Malone KE, Strom BL, Ursin G, Marchbanks PA et al..  2009.  Breast cancer receptor status: do results from a centralized pathology laboratory agree with SEER registry reports? Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(8):2214-20. Abstract
Lord SJ, Bernstein L, Johnson KA, Malone KE, McDonald JA, Marchbanks PA, Simon MS, Strom BL, Press MF, Folger SG et al..  2008.  Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case-control study.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(7):1723-30. Abstract
Press DJ, Sullivan-Halley J, Ursin G, Deapen D, McDonald JA, Strom BL, Norman SA, Simon MS, Marchbanks PA, Folger SG et al..  2011.  Breast cancer risk and ovariectomy, hysterectomy, and tubal sterilization in the women's contraceptive and reproductive experiences study.. American journal of epidemiology. 173(1):38-47. Abstract
Berstad P, Coates RJ, Bernstein L, Folger SG, Malone KE, Marchbanks PA, Weiss LK, Liff JM, McDonald JA, Strom BL et al..  2010.  A case-control study of body mass index and breast cancer risk in white and African-American women.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 19(6):1532-44. Abstract
Elena JW, Steplowski E, Yu K, Hartge P, Tobias GS, Brotzman MJ, Chanock SJ, Stolzenberg-Solomon RZ, Arslan AA, Bueno-de-Mesquita BH et al..  2012.  Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium.. Cancer causes & control : CCC. Abstract
Cossor FI, Adams-Campbell LL, Chlebowski RT, Gunter MJ, Johnson K, Martell RE, McTiernan A, Simon MS, Rohan T, Wallace RB et al..  2013.  Diabetes, metformin use, and colorectal cancer survival in postmenopausal women.. Cancer epidemiology. 37(5):742-9. Abstract
Shikany JM, Redden DT, Neuhouser ML, Chlebowski RT, Rohan TE, Simon MS, Liu S, Lane DS, Tinker L.  2011.  Dietary Glycemic Load, Glycemic Index, and Carbohydrate and Risk of Breast Cancer in the Women's Health Initiative.. Nutrition and cancer. 63(6):899-907. Abstract
Chlebowski RT, Cirillo DJ, Eaton CB, Stefanick ML, Pettinger M, Carbone LD, Johnson KC, Simon MS, Woods NF, Wactawski-Wende J.  2013.  Estrogen alone and joint symptoms in the Women’s Health Initiative randomized trial. Menopause: The Journal of The North American Menopause Society. :1.
Lavasani S, Chlebowski RT, Prentice RL, Kato I, Wactawski-Wende J, Johnson KC, Young A, Rodabough R, Hubbell AF, Mahinbakht A et al..  2015.  Estrogen and colorectal cancer incidence and mortality.. Cancer. Abstract
Simon MS, Chlebowski RT, Wactawski-Wende J, Johnson KC, Muskovitz A, Kato I, Young A, Hubbell AF, Prentice RL.  2012.  Estrogen plus progestin and colorectal cancer incidence and mortality.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(32):3983-90. Abstract
Reding KW, Chen C, Lowe K, Doody DR, Carlson CS, Chen CT, Houck J, Weiss LK, Marchbanks PA, Bernstein L et al..  2012.  Estrogen-related genes and their contribution to racial differences in breast cancer risk.. Cancer causes & control : CCC. 23(5):671-81. Abstract
Reding KW, Carlson CS, Kahsai O, Chen CC, McDavid A, Doody DR, Chen C, Ornelas I, Lowe K, Bernstein L et al..  2012.  Examination of ancestral informative markers and self-reported race with tumor characteristics of breast cancer among black and white women.. Breast cancer research and treatment. Abstract
Chen F, Chen GK, Stram DO, Millikan RC, Ambrosone CB, John EM, Bernstein L, Zheng W, Palmer JR, Hu JJ et al..  2013.  A genome-wide association study of breast cancer in women of African ancestry.. Human genetics. 132(1):39-48. Abstract
Schwartz AG, Ray RM, Cote ML, Abrams J, Sokol RJ, Hendrix SL, Chen C, Chlebowski RT, Hubbell AF, Kooperberg C et al..  2015.  Hormone Use, Reproductive History and Risk of Lung Cancer: The Women's Health Initiative Studies.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. Abstract
Kato I, Lane D, Womack CR, Bock CH, Hou L, Lin JH, Wu C, Beebe Dimmer J, Simon MS.  2017.  Interaction between Nonsteroidal Anti-inflammatory Drugs and Low-fat Dietary Intervention on Colorectal Cancer Incidence; the Women's Health Initiative (WHI) Dietary Modification Trial.. Journal of the American College of Nutrition. :1-8. Abstract
Chlebowski RT, Aragaki AK, Anderson GL, Thomson CA, Manson JE, Simon MS, Howard BV, Rohan TE, Snetselar L, Lane D et al..  2017.  Low-Fat Dietary Pattern and Breast Cancer Mortality in the Women's Health Initiative Randomized Controlled Trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. :JCO2016720326. Abstract
Pan K, Chlebowski RT, Simon MS, Ray RM, Livaudais-Toman J, Sullivan SD, Stefanick ML, Wallace RB, Leboff M, Bluhm EC et al..  2016.  Medication use trajectories of postmenopausal breast cancer survivors and matched cancer-free controls.. Breast cancer research and treatment. 156(3):567-76. Abstract
Kato I, Chlebowski RT, Hou L, Wactawski-Wende J, Ray RM, Abrams J, Bock C, Desai P, Simon MS.  2015.  Menopausal estrogen therapy and non-Hodgkin's lymphoma: A post-hoc analysis of women's health initiative randomized clinical trial.. International journal of cancer. Journal international du cancer. Abstract
Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, Anderson G, Howard BV, Thomson CA, LaCroix AZ et al..  2013.  Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.. JAMA : the journal of the American Medical Association. 310(13):1353-68. Abstract
Ma H, Lu Y, Malone KE, Marchbanks PA, Deapen DM, Spirtas R, Burkman RT, Strom BL, McDonald JA, Folger SG et al..  2013.  Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.. BMC cancer. 13:225. Abstract
Lu Y, Ma H, Malone KE, Norman SA, Sullivan-Halley J, Strom BL, Marchbanks PA, Spirtas R, Burkman RT, Deapen D et al..  2011.  Obesity and survival among black women and white women 35 to 64 years of age at diagnosis with invasive breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(25):3358-65. Abstract
Marchbanks PA, Curtis KM, Mandel MG, Wilson HG, Jeng G, Folger SG, McDonald JA, Daling JR, Bernstein L, Malone KE et al..  2012.  Oral contraceptive formulation and risk of breast cancer.. Contraception. 85(4):342-350. Abstract
Lu Y, Ma H, Malone KE, Norman SA, Sullivan-Halley J, Strom BL, Simon MS, Marchbanks PA, McDonald JA, West DW et al..  2011.  Oral contraceptive use and survival in women with invasive breast cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(7):1391-7. Abstract